The Coalition for Epidemic Preparedness Innovations (CEPI) has recently partnered with the consortium of India-based Bharat Biotech, University of Sydney and ExcellGene to develop “variantproof” COVID-19 vaccine.
The company increases its efficiency and is able to face the growing demand for its services.
The certification will open new avenues for our flagship brand “Dr Trust”, enabling them to export these devices to many more countries
Acquisition brings leading sickle cell disease portfolio and pipeline to Pfizer with potential to address critical needs in an underserved patient community
The reduction in force will result in financial savings of approximately $50 million annually beginning in 2023
Glenmark is the first company in India to launch Thiazolidinedione Lobeglitazone (0.5 mg).
DSCO has requested WHO to share at the earliest with CDSCO the report on establishment of causal relation to death with the medical products in question etc.
The agreement provides for acquisition of 13,50,000 equity shares of Rs. 100 each constituting 50% of the total equity share capital
The two overhead tanks commissioned at a cost of Rs 57 lakh will be maintained by the village panchayats.
Both products are broad-spectrum, foliar insecticides used across wide range of crops
Subscribe To Our Newsletter & Stay Updated
